Reporting of Sample Size Calculations in Analgesic Clinical Trials: ACTTION Systematic Review

被引:21
|
作者
McKeown, Andrew [1 ]
Gewandter, Jennifer S. [1 ]
McDermott, Michael P. [2 ,3 ,4 ]
Pawlowski, Joseph R. [1 ]
Poli, Joseph J. [1 ]
Rothstein, Daniel [1 ]
Farrar, John T. [5 ]
Gilron, Ian [6 ]
Katz, Nathaniel P. [7 ,8 ]
Lin, Allison H. [9 ]
Rappaport, Bob A. [9 ]
Rowbotham, Michael C. [10 ]
Turk, Dennis C. [11 ]
Dworkin, Robert H. [1 ,3 ,4 ]
Smith, Shannon M. [1 ]
机构
[1] Univ Rochester, Sch Med & Dent, Dept Anesthesiol, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA
[4] Univ Rochester, Sch Med & Dent, Ctr Human Expt Therapeut, Rochester, NY 14642 USA
[5] Univ Penn, Philadelphia, PA 19104 USA
[6] Queens Univ, Kingston, ON, Canada
[7] Analges Solut, Natick, MA USA
[8] Tufts Univ, Dept Anesthesiol, Boston, MA 02111 USA
[9] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[10] Calif Pacific Med Ctr, San Francisco, CA USA
[11] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA
来源
JOURNAL OF PAIN | 2015年 / 16卷 / 03期
关键词
Sample size; power; pain research; RANDOMIZED-TRIALS; STATISTICAL POWER; ETHICS;
D O I
10.1016/j.jpain.2014.11.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Sample size calculations determine the number of participants required to have sufficiently high power to detect a given treatment effect. In this review, we examined the reporting quality of sample size calculations in 172 publications of double-blind randomized controlled trials of noninvasive pharmacologic or interventional (ie, invasive) pain treatments published in European Journal of Pain, Journal of Pain, and Pain from January 2006 through June 2013. Sixty-five percent of publications reported a sample size calculation but only 38% provided all elements required to replicate the calculated sample size. In publications reporting at least 1 element, 54% provided a justification for the treatment effect used to calculate sample size, and 24% of studies with continuous outcome variables justified the variability estimate. Publications of clinical pain condition trials reported a sample size calculation more frequently than experimental pain model trials (77% vs 33%, P < .001) but did not differ in the frequency of reporting all required elements. No significant differences in reporting of any or all elements were detected between publications of trials with industry and nonindustry sponsorship. Twenty-eight percent included a discrepancy between the reported number of planned and randomized participants. This study suggests that sample size calculation reporting in analgesic trial publications is usually incomplete. Investigators should provide detailed accounts of sample size calculations in publications of clinical trials of pain treatments, which is necessary for reporting transparency and communication of pre-trial design decisions. Perspective: In this systematic review of analgesic clinical trials, sample size calculations and the required elements (eg, treatment effect to be detected; power level) were incompletely reported. A lack of transparency regarding sample size calculations may raise questions about the appropriateness of the calculated sample size. (C) 2015 by the American Pain Society
引用
收藏
页码:199 / 206
页数:8
相关论文
共 50 条
  • [1] Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations
    Gewandter, Jennifer S.
    Smith, Shannon M.
    McKeown, Andrew
    Burke, Laurie B.
    Hertz, Sharon H.
    Hunsinger, Matthew
    Katz, Nathaniel P.
    Lin, Allison H.
    McDermott, Michael P.
    Rappaport, Bob A.
    Williams, Mark R.
    Turk, Dennis C.
    Dworkin, Robert H.
    PAIN, 2014, 155 (03) : 461 - 466
  • [2] Reporting of intention-to-treat analyses in recent analgesic clinical trials: ACTTION systematic review and recommendations
    Gewandter, Jennifer S.
    McDermott, Michael P.
    McKeown, Andrew
    Smith, Shannon M.
    Pawlowski, Joseph R.
    Poli, Joseph J.
    Rothstein, Daniel
    Williams, Mark R.
    Bujanover, Shay
    Farrar, John T.
    Gilron, Ian
    Katz, Nathaniel P.
    Rowbotham, Michael C.
    Turk, Dennis C.
    Dworkin, Robert H.
    PAIN, 2014, 155 (12) : 2714 - 2719
  • [3] Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations
    Gewandter, J.
    Smith, S.
    McKeown, A.
    Burke, L.
    Hertz, S.
    Hunsinger, M.
    Katz, N.
    Lin, A.
    McDermott, M.
    Rappaport, B.
    Williams, M.
    Turk, D.
    Dworkin, R.
    JOURNAL OF PAIN, 2014, 15 (04): : S41 - S41
  • [4] Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations
    Smith, Shannon M.
    Wang, Anthony T.
    Katz, Nathaniel P.
    McDermott, Michael P.
    Burke, Laurie B.
    Coplan, Paul
    Gilron, Ian
    Hertz, Sharon H.
    Lin, Allison H.
    Rappaport, Bob A.
    Rowbotham, Michael C.
    Sampaio, Cristina
    Sweeney, Michael
    Turk, Dennis C.
    Dworkin, Robert H.
    PAIN, 2013, 154 (07) : 997 - 1008
  • [5] Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review
    Smith, Shannon M.
    Chang, R. Daniel
    Pereira, Anthony
    Shah, Nirupa
    Gilron, Ian
    Katz, Nathaniel P.
    Lin, Allison H.
    McDermott, Michael P.
    Rappaport, Bob A.
    Rowbotham, Michael C.
    Sampaio, Cristina
    Turk, Dennis C.
    Dworkin, Robert H.
    PAIN, 2012, 153 (12) : 2415 - 2421
  • [6] Reporting of cross-over clinical trials of analgesic treatments for neuropathic and musculoskeletal pain: ACTTION systematic review and recommendations
    Gewandter, J.
    McKeown, A.
    McDermott, M.
    Hoang, K.
    Kataryzyna, I.
    Kralovic, S.
    Rothstein, D.
    Gilron, I.
    Katz, N.
    Senn, S.
    Smith, S.
    Turk, D.
    Dworkin, R.
    JOURNAL OF PAIN, 2016, 17 (04): : S13 - S13
  • [7] Reporting of missing data and methods used to accommodate them in recent analgesic clinical trials: ACTTION systematic review and recommendations
    Gewandter, Jennifer S.
    McDermott, Michael P.
    McKeown, Andrew
    Smith, Shannon M.
    Williams, Mark R.
    Hunsinger, Matthew
    Farrar, John
    Turk, Dennis C.
    Dworkin, Robert H.
    PAIN, 2014, 155 (09) : 1871 - 1877
  • [8] Adherence to CONSORT and ACTTION guidelines for adverse event reporting in non-pharmacologic, non-interventional analgesic clinical trials: ACTTION systematic review and recommendations
    Hunsinger, M.
    Smith, S.
    McKeown, A.
    Parkhurst, M.
    McDermott, M.
    Turk, D.
    Dworkin, R.
    JOURNAL OF PAIN, 2014, 15 (04): : S39 - S39
  • [9] Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review
    Hunsinger, Matthew
    Smith, Shannon M.
    Rothstein, Daniel
    McKeown, Andrew
    Parkhurst, Melissa
    Hertz, Sharon
    Katz, Nathaniel P.
    Lin, Allison H.
    McDermott, Michael P.
    Rappaport, Bob A.
    Turk, Dennis C.
    Dworkin, Robert H.
    PAIN, 2014, 155 (11) : 2253 - 2262
  • [10] Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review
    Stavros Nikolakopoulos
    Kit C B Roes
    Johanna H van der Lee
    Ingeborg van der Tweel
    Trials, 15